Efficacy and Safety of Zoledronic Acid Plus Sorafenib for Advanced Hepatocellular Carcinoma Patients: A Single Center, Single Arm, Phase II Clinical Trial

被引：0
|
作者：
Zhang, Lan [1 ]
Xie, Xiaoying [1 ]
Ren, Zheng Gang [1 ]
Sun, Hui Chuan [1 ]
机构：
[1] Fudan Univ, Zhongshan Hosp, Liver Canc Inst, Shanghai, Peoples R China
来源：
HEPATOLOGY | 2018年 / 68卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
359
引用
收藏
页码：216A / 216A
页数：1
相关论文
共 50 条
  • [1] Efficacy and Safety of Bavituximab in Combination with Sorafenib in Advanced Hepatocellular Carcinoma: A Single-Arm, Open-Label, Phase II Clinical Trial
    Ali A. Mokdad
    Hao Zhu
    Muhammad S. Beg
    Yull Arriaga
    Jonathan E. Dowell
    Amit G. Singal
    Adam C. Yopp
    [J]. Targeted Oncology, 2019, 14 : 541 - 550
  • [2] Efficacy and Safety of Bavituximab in Combination with Sorafenib in Advanced Hepatocellular Carcinoma: A Single-Arm, Open-Label, Phase II Clinical Trial
    Mokdad, Ali A.
    Zhu, Hao
    Beg, Muhammad S.
    Arriaga, Yull
    Dowell, Jonathan E.
    Singal, Amit G.
    Yopp, Adam C.
    [J]. TARGETED ONCOLOGY, 2019, 14 (05) : 541 - 550
  • [3] Safety and efficacy of sorafenib in the treatment of advanced hepatocellular carcinoma: a single center experience
    Rodrigo Imedio, Esteban
    Diaz Beveridge, Roberto
    Aparicio Urtasun, Jorge
    Bruixola Campos, Gema
    Lorente Estelles, David
    Fonfria Esparcia, Maria
    Caballero Daroqui, Javier
    Segura Huerta, Angel
    Gimenez Ortiz, Alejandra
    Montalar Salcedo, Joaquin
    [J]. MEDICAL ONCOLOGY, 2014, 31 (05) : 1 - 6
  • [4] Safety and efficacy of sorafenib in the treatment of advanced hepatocellular carcinoma: a single center experience
    Esteban Rodrigo Imedio
    Roberto Díaz Beveridge
    Jorge Aparicio Urtasun
    Gema Bruixola Campos
    David Lorente Estellés
    María Fonfría Esparcia
    Javier Caballero Daroqui
    Ángel Segura Huerta
    Alejandra Giménez Órtiz
    Joaquin Montalar Salcedo
    [J]. Medical Oncology, 2014, 31
  • [5] Efficacy and safety of sorafenib in combination with gemcitabine in patients with advanced hepatocellular carcinoma: A multicenter, open-label, single-arm phase II study
    Srimuninnimit, Vichien
    Sriuranpong, Virote
    Suwanvecho, Suthida
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2014, 10 (03) : 255 - 260
  • [6] Efficacy and safety of a phase II study of sorafenib plus gemcitabine in advanced hepatocellular carcinoma.
    Srimuninnimit, V.
    Sriuranpong, V.
    Suwanvecho, S.
    Soparattanapaisarn, N.
    Ithimakin, S.
    Akewanlop, C.
    Tanasanvimon, S.
    Parinyanitikul, N.
    Kiatikajornthada, N.
    Suwanrusme, H.
    Chaiyarat, W.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [7] Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: Subanalyses of a phase III trial
    Bruix, Jordi
    Raoul, Jean-Luc
    Sherman, Morris
    Mazzaferro, Vincenzo
    Bolondi, Luigi
    Craxi, Antonio
    Galle, Peter R.
    Santoro, Armando
    Beaugrand, Michel
    Sangiovanni, Angelo
    Porta, Camillo
    Gerken, Guido
    Marrero, Jorge A.
    Nadel, Andrea
    Shan, Michael
    Moscovici, Marius
    Voliotis, Dimitris
    Llovet, Josep M.
    [J]. JOURNAL OF HEPATOLOGY, 2012, 57 (04) : 821 - 829
  • [8] EFFICACY AND SAFETY OF SORAFENIB AND CRYOTHERAPY FOR ADVANCED HEPATOCELLULAR CARCINOMA (HCC): A SINGLE CENTER RANDOMIZED STUDY
    Yang, Yongping
    Lu, Yinying
    Wang, Chunping
    Qu, Jianhui
    Chang, Xiujuan
    An, Linjing
    Hu, Ke-Qin
    [J]. HEPATOLOGY, 2011, 54 : 1367A - 1367A
  • [9] Efficacy and safety of anlotinib in patients with advanced malignancy: a single-center, single-arm, phase 2 trial
    Yihebali Chi
    Guangqian Ji
    Jing Zhang
    Haijian Tang
    Yang Yang
    Wei Liu
    Nan Wang
    Chunhui Gao
    Yongkun Sun
    Jinwan Wang
    [J]. International Journal of Clinical Oncology, 2021, 26 : 1611 - 1618
  • [10] Efficacy and safety of anlotinib in patients with advanced malignancy: a single-center, single-arm, phase 2 trial
    Chi, Yihebali
    Ji, Guangqian
    Zhang, Jing
    Tang, Haijian
    Yang, Yang
    Liu, Wei
    Wang, Nan
    Gao, Chunhui
    Sun, Yongkun
    Wang, Jinwan
    [J]. INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2021, 26 (09) : 1611 - 1618
12345